Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Neoplasm Recurrence, Local"" wg kryterium: Temat


Tytuł :
Clinicopathologic features and clinical outcomes of intravenous leiomyomatosis of the uterus: A case series.
Autorzy :
Yu X; Department of Obstetrics and Gynecology, West China Second Hospital, Sichuan University.; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education.
Fu J; Department of Obstetrics and Gynecology, West China Second Hospital, Sichuan University.; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education.
Cao T; Department of Obstetrics and Gynecology, West China Second Hospital, Sichuan University.; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education.
Huang L; Department of Pathology, West China Second Hospital, Sichuan University, Chengdu, Sichuan, China.
Qie M; Department of Obstetrics and Gynecology, West China Second Hospital, Sichuan University.; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education.
Ouyang Y; Department of Obstetrics and Gynecology, West China Second Hospital, Sichuan University.; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Jan 08; Vol. 100 (1), pp. e24228.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Vena Cava, Inferior*
Leiomyomatosis/*diagnosis
Neoplasm Recurrence, Local/*diagnosis
Uterine Neoplasms/*diagnosis
Vascular Neoplasms/*diagnosis
Adult ; Female ; Humans ; Leiomyomatosis/diagnostic imaging ; Leiomyomatosis/pathology ; Leiomyomatosis/surgery ; Middle Aged ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/surgery ; Retrospective Studies ; Tomography, X-Ray Computed ; Treatment Outcome ; Uterine Neoplasms/diagnostic imaging ; Uterine Neoplasms/pathology ; Uterine Neoplasms/surgery ; Vascular Neoplasms/diagnostic imaging ; Vascular Neoplasms/pathology ; Vascular Neoplasms/surgery
Czasopismo naukowe
Tytuł :
Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy.
Autorzy :
Lechner M; UCL Cancer Institute, University College London, London, UK. .; Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Palo Alto, CA, USA. .; Barts Health NHS Trust, London, UK. .; Royal National Throat, Nose and Ear Hospital and Head and Neck Centre, University College London Hospitals NHS Trust, London, UK. .
Schartinger VH; Department of Otorhinolaryngology, Medical University of Innsbruck, Innsbruck, Austria.
Steele CD; UCL Cancer Institute, University College London, London, UK.
Nei WL; Divisions of Radiation Oncology and Medical Sciences, National Cancer Centre, Singapore, Singapore.; Oncology Academic Programme, Duke-NUS Medical School, Singapore, Singapore.
Ooft ML; King´s College Hospitals, NHS Foundation Trust, London, UK.; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Schreiber LM; Institute of Virology and Christian Doppler Laboratory for Viral Immunotherapy of Cancer, Medical University of Innsbruck, Innsbruck, Austria.
Pipinikas CP; UCL Cancer Institute, University College London, London, UK.
Chung GT; Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong, China.
Chan YY; Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong, China.
Wu F; Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong, China.
To KF; Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong, China.
Tsang CM; Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong, China.
Pearce W; UCL Cancer Institute, University College London, London, UK.
Morelli D; UCL Cancer Institute, University College London, London, UK.
Philpott M; Botnar Research Centre, University of Oxford, Oxford, UK.
Masterson L; Department of Otolaryngology, Addenbrooke's Hospital, Cambridge, UK.
Nibhani R; Botnar Research Centre, University of Oxford, Oxford, UK.
Wells G; Botnar Research Centre, University of Oxford, Oxford, UK.
Bell CG; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Koller J; Department of Otorhinolaryngology, Medical University of Innsbruck, Innsbruck, Austria.; Botnar Research Centre, University of Oxford, Oxford, UK.
Delecluse S; German Cancer Research Centre (DKFZ) and Inserm, Unit F100/U1074, Heidelberg, Germany.
Yip YL; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.
Liu J; UCL Cancer Institute, University College London, London, UK.
Forde CT; Royal National Throat, Nose and Ear Hospital and Head and Neck Centre, University College London Hospitals NHS Trust, London, UK.
Forster MD; UCL Cancer Institute, University College London, London, UK.; Royal National Throat, Nose and Ear Hospital and Head and Neck Centre, University College London Hospitals NHS Trust, London, UK.
Jay A; Department of Histopathology, University College London Hospitals NHS Trust, Euston Road, London, UK.
Dudás J; Department of Otorhinolaryngology, Medical University of Innsbruck, Innsbruck, Austria.
Krapp A; Department of Otorhinolaryngology, Medical University of Innsbruck, Innsbruck, Austria.
Wan S; Institute of Nuclear Medicine, University College Hospital, Euston Road, London, UK.
Uprimny C; Department of Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austria.
Sprung S; Department of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, Innsbruck, Austria.
Haybaeck J; Department of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, Innsbruck, Austria.; Diagnostic & Research Center for Molecular Biomedicine, Institute of Pathology, Medical University of Graz, Graz, Austria.
Fenton TR; School of Biosciences, University of Kent, Canterbury, UK.
Chester K; UCL Cancer Institute, University College London, London, UK.
Thirlwell C; UCL Cancer Institute, University College London, London, UK.; University of Exeter College of Medicine and Health, Exeter, UK.
Royle G; UCL Cancer Institute, University College London, London, UK.
Marafioti T; UCL Cancer Institute, University College London, London, UK.
Gupta R; UCL Cancer Institute, University College London, London, UK.
Indrasari SR; ENT Head and Neck Surgery Department, Universitas Gadjah Mada, Dr. Sardjito Hospital, Yogyakarta, Indonesia.
Herdini C; ENT Head and Neck Surgery Department, Universitas Gadjah Mada, Dr. Sardjito Hospital, Yogyakarta, Indonesia.
Slim MAM; Department of Ear, Nose and Throat, University Hospital Crosshouse, Crosshouse, Kilmarnock, UK.
Indrawati I; Department of Anatomical Pathology, Universitas Gadjah Mada, Dr. Sardjito Hospital, Yogyakarta, Indonesia.
Sutton L; Barts Health NHS Trust, London, UK.
Fles R; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Tan B; ENT Head and Neck Surgery Department, Universitas Gadjah Mada, Dr. Sardjito Hospital, Yogyakarta, Indonesia.; Department of ENT/Head and Neck Surgery, Maastricht University Medical Center (MUMC), Maastricht, The Netherlands.
Yeong J; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.; Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore.
Jain A; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.
Han S; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.
Wang H; Divisions of Radiation Oncology and Medical Sciences, National Cancer Centre, Singapore, Singapore.
Loke KSH; Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, Singapore, Singapore.
He W; Department of Oncology, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China.
Xu R; Department of Oncology, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China.
Jin H; Department of Pathology, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China.
Cheng Z; Department of Pathology, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China.
Howard D; Royal National Throat, Nose and Ear Hospital and Head and Neck Centre, University College London Hospitals NHS Trust, London, UK.; ENT Department, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
Hwang PH; Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Palo Alto, CA, USA.
Le QT; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA, USA.
Tay JK; Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, USA.; Department of Otolaryngology-Head and Neck Surgery, National University of Singapore, Singapore, Singapore.
West RB; Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, USA.
Tsao SW; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.
Meyer T; UCL Cancer Institute, University College London, London, UK.
Riechelmann H; Department of Otorhinolaryngology, Medical University of Innsbruck, Innsbruck, Austria.
Oppermann U; Botnar Research Centre, University of Oxford, Oxford, UK.; Freiburg Institute for Advanced Studies (FRIAS), University of Freiburg, 79085, Freiburg, Germany.
Delecluse HJ; German Cancer Research Centre (DKFZ) and Inserm, Unit F100/U1074, Heidelberg, Germany.
Willems SM; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Pathology, University Medical Center Groningen, Groningen, The Netherlands.
Chua MLK; Divisions of Radiation Oncology and Medical Sciences, National Cancer Centre, Singapore, Singapore.; Oncology Academic Programme, Duke-NUS Medical School, Singapore, Singapore.
Busson P; CNRS-UMR 9018-METSY, Gustave Roussy and Université Paris-Saclay, Villejuif, France.
Lo KW; Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong, China.
Wollmann G; Institute of Virology and Christian Doppler Laboratory for Viral Immunotherapy of Cancer, Medical University of Innsbruck, Innsbruck, Austria.
Pillay N; UCL Cancer Institute, University College London, London, UK.; Department of Cellular and Molecular Pathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, UK.
Vanhaesebroeck B; UCL Cancer Institute, University College London, London, UK. .
Lund VJ; UCL Cancer Institute, University College London, London, UK. .; Royal National Throat, Nose and Ear Hospital and Head and Neck Centre, University College London Hospitals NHS Trust, London, UK. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Jan 05; Vol. 12 (1), pp. 117. Date of Electronic Publication: 2021 Jan 05.
Typ publikacji :
Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Epstein-Barr Virus Infections/*genetics
Nasopharyngeal Carcinoma/*genetics
Nasopharyngeal Neoplasms/*genetics
Neoplasm Recurrence, Local/*genetics
Receptors, Somatostatin/*genetics
Viral Matrix Proteins/*genetics
Animals ; Antineoplastic Agents/pharmacology ; Cell Line, Tumor ; Epstein-Barr Virus Infections/drug therapy ; Epstein-Barr Virus Infections/mortality ; Epstein-Barr Virus Infections/virology ; Female ; Herpesvirus 4, Human/drug effects ; Herpesvirus 4, Human/growth & development ; Herpesvirus 4, Human/pathogenicity ; Host-Pathogen Interactions/genetics ; Humans ; Lymphatic Metastasis ; Male ; Mice ; Mice, Nude ; Molecular Targeted Therapy ; NF-kappa B/genetics ; NF-kappa B/metabolism ; Nasopharyngeal Carcinoma/drug therapy ; Nasopharyngeal Carcinoma/mortality ; Nasopharyngeal Carcinoma/virology ; Nasopharyngeal Neoplasms/drug therapy ; Nasopharyngeal Neoplasms/mortality ; Nasopharyngeal Neoplasms/virology ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/mortality ; Neoplasm Recurrence, Local/virology ; Octreotide/pharmacology ; Positron Emission Tomography Computed Tomography ; Receptors, Somatostatin/antagonists & inhibitors ; Receptors, Somatostatin/metabolism ; Signal Transduction ; Survival Analysis ; Viral Matrix Proteins/antagonists & inhibitors ; Viral Matrix Proteins/metabolism ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Oncologic and functional outcomes following laryngectomy for locally advanced thyroid cancer.
Autorzy :
Flukes S; Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
Cohen MA; Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
Cunningham LM; Speech and Language Pathology, Speech and Hearing Center, Rehabilitation Services, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
Wong RJ; Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
Cracchiolo JR; Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
Pokaż więcej
Źródło :
Journal of surgical oncology [J Surg Oncol] 2021 Jan; Vol. 123 (1), pp. 149-155. Date of Electronic Publication: 2020 Oct 15.
Typ publikacji :
Journal Article
MeSH Terms :
Quality of Life*
Laryngeal Neoplasms/*mortality
Laryngectomy/*mortality
Neoplasm Recurrence, Local/*mortality
Postoperative Complications/*mortality
Thyroid Neoplasms/*mortality
Adult ; Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Humans ; Laryngeal Neoplasms/pathology ; Laryngeal Neoplasms/surgery ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/surgery ; Postoperative Complications/pathology ; Postoperative Complications/surgery ; Prognosis ; Retrospective Studies ; Survival Rate ; Thyroid Neoplasms/pathology ; Thyroid Neoplasms/surgery
Czasopismo naukowe
Tytuł :
Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment.
Autorzy :
Tseng JS; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan.
Hsu KH; Division of Critical Care and Respiratory Therapy, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Zheng ZR; Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
Yang TY; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Chen KC; Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Department of Applied Chemistry, National Chi Nan University, Nantou, Taiwan.
Huang YH; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan.
Su KY; Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Yu SL; Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Center of Genomic Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Pathology and Graduate Institute of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan.; Center for Optoelectronic Biomedicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Chang GC; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, .; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan, .; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan, .; Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan, .; School of Medicine, Chung Shan Medical University, Taichung, Taiwan, .; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, .
Pokaż więcej
Źródło :
Oncology [Oncology] 2021; Vol. 99 (1), pp. 32-40. Date of Electronic Publication: 2020 Sep 07.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma of Lung/*surgery
Neoplasm Recurrence, Local/*surgery
Protein Kinase Inhibitors/*administration & dosage
Adenocarcinoma of Lung/drug therapy ; Adenocarcinoma of Lung/genetics ; Adenocarcinoma of Lung/pathology ; Aged ; Aged, 80 and over ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/genetics ; Female ; Humans ; Male ; Middle Aged ; Mutation/genetics ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/genetics ; Progression-Free Survival ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Actual 10-year survivors and 10-year recurrence free survivors after primary liver resection for hepatocellular carcinoma in the 21st century: A single institution contemporary experience.
Autorzy :
Linn YL; Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore, Singapore.
Chee MY; Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore, Singapore.
Koh YX; Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore, Singapore.; Duke-National University of Singapore Medical School, Singapore, Singapore.
Teo JY; Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore, Singapore.; Duke-National University of Singapore Medical School, Singapore, Singapore.
Cheow PC; Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore, Singapore.; Duke-National University of Singapore Medical School, Singapore, Singapore.
Chow PKH; Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore, Singapore.; Duke-National University of Singapore Medical School, Singapore, Singapore.
Chan CY; Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore, Singapore.; Duke-National University of Singapore Medical School, Singapore, Singapore.
Chung AYF; Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore, Singapore.; Duke-National University of Singapore Medical School, Singapore, Singapore.
Ooi LLPJ; Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore, Singapore.; Duke-National University of Singapore Medical School, Singapore, Singapore.
Goh BKP; Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore, Singapore.; Duke-National University of Singapore Medical School, Singapore, Singapore.
Pokaż więcej
Źródło :
Journal of surgical oncology [J Surg Oncol] 2021 Jan; Vol. 123 (1), pp. 214-221. Date of Electronic Publication: 2020 Oct 23.
Typ publikacji :
Clinical Trial; Journal Article
MeSH Terms :
Cancer Survivors/*statistics & numerical data
Carcinoma, Hepatocellular/*mortality
Hepatectomy/*mortality
Liver Neoplasms/*mortality
Liver Transplantation/*mortality
Neoplasm Recurrence, Local/*mortality
Aged ; Carcinoma, Hepatocellular/pathology ; Carcinoma, Hepatocellular/surgery ; Female ; Follow-Up Studies ; Humans ; Liver Neoplasms/pathology ; Liver Neoplasms/surgery ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/surgery ; Prognosis ; Prospective Studies ; Retrospective Studies ; Survival Rate ; Time Factors
Czasopismo naukowe
Tytuł :
Ten-year survival after pathologic complete response in rectal adenocarcinoma.
Autorzy :
Sell NM; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Qwaider YZ; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Goldstone RN; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Cauley CE; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Cusack JC; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Ricciardi R; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Bordeianou LG; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Berger DL; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Kunitake H; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
Journal of surgical oncology [J Surg Oncol] 2021 Jan; Vol. 123 (1), pp. 293-298. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma/*mortality
Chemoradiotherapy, Adjuvant/*mortality
Digestive System Surgical Procedures/*mortality
Neoadjuvant Therapy/*mortality
Neoplasm Recurrence, Local/*mortality
Rectal Neoplasms/*mortality
Adenocarcinoma/secondary ; Adenocarcinoma/therapy ; Adult ; Aged ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/therapy ; Prognosis ; Rectal Neoplasms/pathology ; Rectal Neoplasms/therapy ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
Characterising the immune microenvironment in liposarcoma, its impact on prognosis and the impact of radiotherapy.
Autorzy :
Snow H; Peter MacCallum Cancer Centre, Melbourne, Australia.
Mitchell C; Peter MacCallum Cancer Centre, Melbourne, Australia.
Hendry S; Peter MacCallum Cancer Centre, Melbourne, Australia.
McKinley M; Peter MacCallum Cancer Centre, Melbourne, Australia.
Byrne D; Peter MacCallum Cancer Centre, Melbourne, Australia.
Ngan S; Peter MacCallum Cancer Centre, Melbourne, Australia.
Chander S; Peter MacCallum Cancer Centre, Melbourne, Australia.
Chu J; Peter MacCallum Cancer Centre, Melbourne, Australia.
Desai J; Peter MacCallum Cancer Centre, Melbourne, Australia.
Bae S; Peter MacCallum Cancer Centre, Melbourne, Australia.
Henderson M; Peter MacCallum Cancer Centre, Melbourne, Australia.
Choong P; Peter MacCallum Cancer Centre, Melbourne, Australia.
Gyorki D; Peter MacCallum Cancer Centre, Melbourne, Australia.
Pokaż więcej
Źródło :
Journal of surgical oncology [J Surg Oncol] 2021 Jan; Vol. 123 (1), pp. 117-126. Date of Electronic Publication: 2020 Oct 20.
Typ publikacji :
Journal Article
MeSH Terms :
CD8-Positive T-Lymphocytes/*immunology
Liposarcoma/*immunology
Lymphocytes, Tumor-Infiltrating/*immunology
Neoplasm Recurrence, Local/*immunology
Radiotherapy/*methods
Tumor Microenvironment/*immunology
Adolescent ; Adult ; Aged ; CD8-Positive T-Lymphocytes/radiation effects ; Female ; Follow-Up Studies ; Humans ; Liposarcoma/pathology ; Liposarcoma/radiotherapy ; Lymphocytes, Tumor-Infiltrating/radiation effects ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/radiotherapy ; Prognosis ; Retrospective Studies ; Tumor Microenvironment/radiation effects ; Young Adult
Czasopismo naukowe
Tytuł :
Correlation of PRL3 expression with colorectal cancer progression.
Autorzy :
Leiphrakpam PD; Department of Surgery, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Lazenby AJ; Department of Pathology and Microbiology, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Smith LM; Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Brattain MG; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Black JD; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Wang J; Department of Cancer Biology and Genetics, College of Medicine, Ohio State University, Columbus, Ohio, USA.
Are C; Division of Surgical Oncology, Department of Surgery, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Pokaż więcej
Źródło :
Journal of surgical oncology [J Surg Oncol] 2021 Jan; Vol. 123 (1), pp. 42-51. Date of Electronic Publication: 2020 Nov 12.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma/*pathology
Biomarkers, Tumor/*metabolism
Carcinoma, Signet Ring Cell/*pathology
Colorectal Neoplasms/*pathology
Neoplasm Proteins/*metabolism
Neoplasm Recurrence, Local/*pathology
Protein Tyrosine Phosphatases/*metabolism
Adenocarcinoma/metabolism ; Adenocarcinoma/therapy ; Aged ; Carcinoma, Signet Ring Cell/metabolism ; Carcinoma, Signet Ring Cell/therapy ; Colorectal Neoplasms/metabolism ; Colorectal Neoplasms/therapy ; Combined Modality Therapy ; Disease Progression ; Female ; Follow-Up Studies ; Humans ; Male ; Neoplasm Recurrence, Local/metabolism ; Neoplasm Recurrence, Local/therapy ; Prognosis ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
Leveraging the increased rates of pathologic complete response after neoadjuvant treatment in breast cancer to de-escalate surgical treatments.
Autorzy :
Esgueva A; Department of Breast Surgical Oncology, Clinica Universidad de Navarra, Universidad de Navarra, Madrid, Spain.
Siso C; Department of Breast Surgical Oncology, Hospital Universitario Vall d'Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain.
Espinosa-Bravo M; Department of Breast Surgical Oncology, Hospital Universitario Vall d'Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain.
Sobrido C; Breast Imaging Unit, Department of Radiology, Clinica Universidad de Navarra, Universidad de Navarra, Madrid, Spain.
Miranda I; Breast Imaging Unit, Department of Radiology, Hospital Universitario Vall d'Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain.
Salazar JP; Breast Imaging Unit, Department of Radiology, Hospital Universitario Vall d'Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain.
Rubio IT; Department of Breast Surgical Oncology, Clinica Universidad de Navarra, Universidad de Navarra, Madrid, Spain.
Pokaż więcej
Źródło :
Journal of surgical oncology [J Surg Oncol] 2021 Jan; Vol. 123 (1), pp. 71-79. Date of Electronic Publication: 2020 Oct 01.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms/*pathology
Carcinoma, Ductal, Breast/*secondary
Carcinoma, Lobular/*secondary
Mastectomy/*mortality
Neoadjuvant Therapy/*mortality
Neoplasm Recurrence, Local/*pathology
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Breast Neoplasms/drug therapy ; Breast Neoplasms/surgery ; Carcinoma, Ductal, Breast/drug therapy ; Carcinoma, Ductal, Breast/surgery ; Carcinoma, Lobular/drug therapy ; Carcinoma, Lobular/surgery ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Lymphatic Metastasis ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/surgery ; Prognosis ; Prospective Studies ; Sentinel Lymph Node Biopsy ; Survival Rate ; Young Adult
Czasopismo naukowe
Tytuł :
Predictive value of tumor-infiltrating lymphocytes for response to neoadjuvant chemotherapy and breast cancer prognosis.
Autorzy :
Li X; West China School of Medicine, West China Hospital, Sichuan University, Chengdu, China.
Tan Q; Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.
Li H; Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.
Yang X; Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.
Pokaż więcej
Źródło :
Journal of surgical oncology [J Surg Oncol] 2021 Jan; Vol. 123 (1), pp. 89-95. Date of Electronic Publication: 2020 Oct 12.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Lymph Nodes/*immunology
Lymphocytes, Tumor-Infiltrating/*immunology
Neoadjuvant Therapy/*mortality
Neoplasm Recurrence, Local/*immunology
Neoplasm, Residual/*immunology
Triple Negative Breast Neoplasms/*immunology
Adult ; Female ; Follow-Up Studies ; Humans ; Lymph Nodes/drug effects ; Lymph Nodes/pathology ; Lymphocytes, Tumor-Infiltrating/drug effects ; Lymphocytes, Tumor-Infiltrating/pathology ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Neoplasm, Residual/drug therapy ; Neoplasm, Residual/pathology ; Prognosis ; Retrospective Studies ; Survival Rate ; Triple Negative Breast Neoplasms/drug therapy ; Triple Negative Breast Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Outcomes of neoadjuvant therapy for cholangiocarcinoma: A review of existing evidence assessing treatment response and R0 resection rate.
Autorzy :
Le VH; Department of Surgery, City of Hope National Medical Center, Duarte, California, USA.
O'Connor VV; Department of Surgery, Kaiser Permanente - Los Angeles Medical Center, Los Angeles, California, USA.
Li D; Department of Medical Oncology and Therapeutic Research, City of Hope National Medical Center, Duarte, California, USA.
Melstrom LG; Department of Surgery, City of Hope National Medical Center, Duarte, California, USA.
Fong Y; Department of Surgery, City of Hope National Medical Center, Duarte, California, USA.
DiFronzo AL; Department of Surgery, Kaiser Permanente - Los Angeles Medical Center, Los Angeles, California, USA.
Pokaż więcej
Źródło :
Journal of surgical oncology [J Surg Oncol] 2021 Jan; Vol. 123 (1), pp. 164-171. Date of Electronic Publication: 2020 Sep 24.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Bile Duct Neoplasms/*mortality
Cholangiocarcinoma/*mortality
Neoadjuvant Therapy/*mortality
Neoplasm Recurrence, Local/*mortality
Bile Duct Neoplasms/drug therapy ; Bile Duct Neoplasms/surgery ; Cholangiocarcinoma/drug therapy ; Cholangiocarcinoma/surgery ; Humans ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/surgery ; Prognosis
Czasopismo naukowe
Tytuł :
Even a partial pathological response is associated with lower relapse rates in patients with operable rectal cancer undergoing neoadjuvant chemotherapy.
Autorzy :
Koizumi M; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Yamada T; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Shinji S; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Matsuda A; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Yokoyama Y; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Takahashi G; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Iwai T; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Takeda K; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Hara K; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Yoshida H; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Pokaż więcej
Źródło :
Journal of surgical oncology [J Surg Oncol] 2021 Jan; Vol. 123 (1), pp. 286-292. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma/*mortality
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Neoplasm Recurrence, Local/*mortality
Rectal Neoplasms/*mortality
Adenocarcinoma/drug therapy ; Adenocarcinoma/secondary ; Adult ; Aged ; Clinical Trials, Phase II as Topic ; Female ; Fluorouracil/administration & dosage ; Follow-Up Studies ; Humans ; Leucovorin/administration & dosage ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Oxaliplatin/administration & dosage ; Prognosis ; Prospective Studies ; Rectal Neoplasms/drug therapy ; Rectal Neoplasms/pathology ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
Multidisciplinary Management of Angiosarcoma - A Review.
Autorzy :
Sturm EC; Roger Williams Medical Center, Department of Surgery, Providence, Rhode Island.
Marasco IS; Roger Williams Medical Center, Department of Medicine and Immuno-Oncology Institute, Providence, Rhode Island.
Katz SC; Roger Williams Medical Center, Department of Medicine and Immuno-Oncology Institute, Providence, Rhode Island; Boston University School of Medicine, Department of Surgery, Boston, Massachusetts. Electronic address: .
Pokaż więcej
Źródło :
The Journal of surgical research [J Surg Res] 2021 Jan; Vol. 257, pp. 213-220. Date of Electronic Publication: 2020 Aug 25.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Patient Care Team*
Hemangiosarcoma/*therapy
Neoplasm Recurrence, Local/*prevention & control
Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Blood Vessels/pathology ; Blood Vessels/radiation effects ; Chemotherapy, Adjuvant ; Clinical Trials, Phase II as Topic ; Hemangiosarcoma/genetics ; Hemangiosarcoma/mortality ; Hemangiosarcoma/pathology ; Humans ; Lymphatic Vessels/pathology ; Lymphatic Vessels/radiation effects ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/pathology ; Progression-Free Survival ; Radiotherapy, Adjuvant ; Surgical Procedures, Operative
Czasopismo naukowe
Tytuł :
Analysis of Serum Markers with Regard to Treatment Procedures in Advanced Stage Prostate Cancer Patients.
Autorzy :
Wolny-Rokicka E; Department of Radiotherapy, Multidisciplinary Hospital in Gorzów Wielkopolski, Gorzów Wielkopolski, Poland.
Petrasz P; Department of Urology, Multidisciplinary Hospital in Gorzów Wielkopolski, Gorzów Wielkopolski, Poland.
Krajewski W; Department of Urology and Oncologic Urology, Wrocław Medical University, Wrocław, Poland.
Sulimiera Michalak S; Primary Medical Care Clinic 'Skarbowa', Zielona Góra, Poland.
Tukiendorf A; Social Medicine Department, Medical University in Wrocław, Wrocław, Poland.
Pokaż więcej
Źródło :
Medical science monitor : international medical journal of experimental and clinical research [Med Sci Monit] 2020 Dec 16; Vol. 26, pp. e925860. Date of Electronic Publication: 2020 Dec 16.
Typ publikacji :
Journal Article
MeSH Terms :
DNA Methylation*
Neoplasm Recurrence, Local*/blood
Neoplasm Recurrence, Local*/diagnosis
Prostatic Neoplasms*/blood
Prostatic Neoplasms*/pathology
Prostatic Neoplasms*/surgery
Cell-Free Nucleic Acids/*blood
P-Selectin/*blood
Receptors, Tumor Necrosis Factor, Type I/*blood
Receptors, Tumor Necrosis Factor, Type II/*blood
Aged ; Apoptosis ; Biomarkers/blood ; Humans ; Male ; Neoplasm Staging ; Prognosis ; Prostatectomy/adverse effects ; Prostatectomy/methods ; Prostatectomy/statistics & numerical data ; Risk Assessment/methods
Czasopismo naukowe
Tytuł :
[Postoperative Follow-Up for Stage Ⅱ Low Rectal Cancer with Curative Surgery].
Autorzy :
Sato H; Dept. of Surgery, Fujita Health University.
Koide Y
Toyama K
Morise Z
Uyama I
Pokaż więcej
Źródło :
Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2020 Dec; Vol. 47 (13), pp. 1753-1755.
Typ publikacji :
Journal Article
MeSH Terms :
Neoplasm Recurrence, Local*/pathology
Neoplasm Recurrence, Local*/surgery
Rectal Neoplasms*/pathology
Rectal Neoplasms*/surgery
CA-19-9 Antigen ; Follow-Up Studies ; Humans ; Neoplasm Staging ; Prognosis ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18-12.
Autorzy :
Park JH; Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of Korea.
Chun SH; Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Republic of Korea.
Lee YG; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Chang H; Department of Internal Medicine, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, Republic of Korea.
Lee KW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Kim HR; Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
Shin SH; Department of Internal Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Republic of Korea.
An HJ; Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Republic of Korea.
Lee KE; Department of Hematology and Oncology, Ewha Woman's University Hospital, Seoul, Republic of Korea.
Hwang IG; Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
Ahn MJ; Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Kim SB; Department of Internal Medicine, Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea. .
Keam B; Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. .
Pokaż więcej
Źródło :
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2020 Dec; Vol. 146 (12), pp. 3359-3369. Date of Electronic Publication: 2020 Jul 15.
Typ publikacji :
Journal Article
MeSH Terms :
Immune Checkpoint Inhibitors/*administration & dosage
Mouth/*drug effects
Neoplasm Recurrence, Local/*drug therapy
Squamous Cell Carcinoma of Head and Neck/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Cell Proliferation/drug effects ; Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Mouth/pathology ; Neoplasm Recurrence, Local/immunology ; Neoplasm Recurrence, Local/pathology ; Progression-Free Survival ; Republic of Korea/epidemiology ; Squamous Cell Carcinoma of Head and Neck/epidemiology ; Squamous Cell Carcinoma of Head and Neck/immunology ; Squamous Cell Carcinoma of Head and Neck/pathology
Czasopismo naukowe
Tytuł :
The combined ratio of estrogen, progesterone, Ki-67, and P53 to predict the recurrence of endometrial cancer.
Autorzy :
Jia M; Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Jiang P; Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Huang Z; Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Hu J; Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Deng Y; Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Hu Z; Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Pokaż więcej
Źródło :
Journal of surgical oncology [J Surg Oncol] 2020 Dec; Vol. 122 (8), pp. 1808-1814. Date of Electronic Publication: 2020 Sep 12.
Typ publikacji :
Journal Article
MeSH Terms :
Biomarkers, Tumor/*metabolism
Endometrial Neoplasms/*surgery
Ki-67 Antigen/*metabolism
Neoplasm Recurrence, Local/*diagnosis
Receptors, Estrogen/*metabolism
Receptors, Progesterone/*metabolism
Tumor Suppressor Protein p53/*metabolism
Adult ; Aged ; Aged, 80 and over ; China/epidemiology ; Endometrial Neoplasms/pathology ; Female ; Follow-Up Studies ; Humans ; Incidence ; Middle Aged ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Recurrence, Local/metabolism ; Prognosis ; Retrospective Studies ; Survival Rate ; Young Adult
Czasopismo naukowe
Tytuł :
Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high-volume liver surgery center in East Asia.
Autorzy :
Liu YW; Department of Surgery, Liver Transplantation Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Yong CC; Department of Surgery, Liver Transplantation Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Lin CC; Department of Surgery, Liver Transplantation Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Wang CC; Department of Surgery, Liver Transplantation Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Chen CL; Department of Surgery, Liver Transplantation Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Cheng YF; Department of Diagnostic Radiology, Liver Transplantation Center, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Wang JH; Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Yen YH; Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Chen CH; Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Pokaż więcej
Źródło :
Journal of surgical oncology [J Surg Oncol] 2020 Dec; Vol. 122 (8), pp. 1587-1594. Date of Electronic Publication: 2020 Aug 19.
Typ publikacji :
Journal Article
MeSH Terms :
Patient Selection*
Carcinoma, Hepatocellular/*surgery
Hepatectomy/*methods
Hospitals, High-Volume/*statistics & numerical data
Liver Neoplasms/*surgery
Neoplasm Recurrence, Local/*surgery
Practice Guidelines as Topic/*standards
Aged ; Carcinoma, Hepatocellular/epidemiology ; Carcinoma, Hepatocellular/pathology ; Far East/epidemiology ; Female ; Follow-Up Studies ; Humans ; Liver Neoplasms/epidemiology ; Liver Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Intraoperative ultrasonography-guided surgery for malignant soft tissue tumor.
Autorzy :
Takeuchi A; Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
Yamamoto N; Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
Hayashi K; Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
Miwa S; Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
Igarashi K; Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
Yonezawa H; Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
Morinaga S; Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
Araki Y; Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
Asano Y; Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
Ikeda H; Division of Pathology, Kanazawa University Hospital, Kanazawa, Japan.
Tsuchiya H; Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
Pokaż więcej
Źródło :
Journal of surgical oncology [J Surg Oncol] 2020 Dec; Vol. 122 (8), pp. 1791-1801. Date of Electronic Publication: 2020 Aug 19.
Typ publikacji :
Journal Article
MeSH Terms :
Intraoperative Care*
Neoplasm Recurrence, Local/*surgery
Sarcoma/*surgery
Surgery, Computer-Assisted/*methods
Ultrasonography/*methods
Adult ; Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Humans ; Male ; Margins of Excision ; Middle Aged ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Retrospective Studies ; Sarcoma/diagnostic imaging ; Sarcoma/pathology ; Survival Rate
Czasopismo naukowe
Tytuł :
Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study.
Autorzy :
Hill RM; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne, UK.
Richardson S; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne, UK.
Schwalbe EC; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne, UK; Department of Applied Sciences, Northumbria University, Newcastle upon Tyne, UK.
Hicks D; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne, UK.
Lindsey JC; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne, UK.
Crosier S; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne, UK.
Rafiee G; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne, UK; School of Electronics, Electrical Engineering and Computer Science, Queen's University Belfast, Centre for Cancer Research & Cell Biology, UK.
Grabovska Y; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne, UK.
Wharton SB; Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.
Jacques TS; Neural Development Unit, UCL Institute of Child Health, London, UK.
Michalski A; Neural Development Unit, UCL Institute of Child Health, London, UK.
Joshi A; Department of Neuropathology, Royal Victoria Infirmary, Newcastle University Teaching Hospitals, NHS Foundation Trust, Newcastle upon Tyne, UK.
Pizer B; Institute of Translational Research, University of Liverpool, Liverpool, UK.
Williamson D; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne, UK.
Bailey S; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne, UK.
Clifford SC; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne, UK. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Child & adolescent health [Lancet Child Adolesc Health] 2020 Dec; Vol. 4 (12), pp. 865-874. Date of Electronic Publication: 2020 Oct 22.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Cerebellar Neoplasms/*therapy
Medulloblastoma/*therapy
Neoplasm Recurrence, Local/*therapy
Adolescent ; Case-Control Studies ; Cerebellar Neoplasms/classification ; Cerebellar Neoplasms/mortality ; Cerebellar Neoplasms/pathology ; Child ; Child, Preschool ; Craniospinal Irradiation/statistics & numerical data ; Disease-Free Survival ; Female ; Humans ; Infant ; Male ; Medulloblastoma/classification ; Medulloblastoma/mortality ; Medulloblastoma/pathology ; Neoplasm Recurrence, Local/diagnosis ; Neoplasm Recurrence, Local/mortality ; Neoplasm Recurrence, Local/pathology ; Retrospective Studies ; Time Factors
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies